[go: up one dir, main page]

DK2455064T3 - Indretning til behandling af periodontal sygdom - Google Patents

Indretning til behandling af periodontal sygdom Download PDF

Info

Publication number
DK2455064T3
DK2455064T3 DK11186418.7T DK11186418T DK2455064T3 DK 2455064 T3 DK2455064 T3 DK 2455064T3 DK 11186418 T DK11186418 T DK 11186418T DK 2455064 T3 DK2455064 T3 DK 2455064T3
Authority
DK
Denmark
Prior art keywords
treatment
periodontal disease
periodontal
disease
Prior art date
Application number
DK11186418.7T
Other languages
English (en)
Inventor
Avi Avramoff
Eyal Shoshani
Adel Penhasi
Dan Oren
Original Assignee
Dexcel Pharma Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dexcel Pharma Technologies Ltd filed Critical Dexcel Pharma Technologies Ltd
Application granted granted Critical
Publication of DK2455064T3 publication Critical patent/DK2455064T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063Periodont
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007Drug-containing films, membranes or sheets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK11186418.7T 2010-10-25 2011-10-25 Indretning til behandling af periodontal sygdom DK2455064T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40628810P 2010-10-25 2010-10-25

Publications (1)

Publication Number Publication Date
DK2455064T3 true DK2455064T3 (da) 2021-02-22

Family

ID=44862663

Family Applications (1)

Application Number Title Priority Date Filing Date
DK11186418.7T DK2455064T3 (da) 2010-10-25 2011-10-25 Indretning til behandling af periodontal sygdom

Country Status (7)

Country Link
US (3) US8865198B2 (da)
EP (1) EP2455064B1 (da)
DE (1) DE202011111037U1 (da)
DK (1) DK2455064T3 (da)
ES (1) ES2842430T3 (da)
IL (1) IL215782A (da)
PT (1) PT2455064T (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8865198B2 (en) * 2010-10-25 2014-10-21 Dexcel Pharma Technologies Ltd. Method for treating a periodontal disease
US9841557B2 (en) 2013-07-10 2017-12-12 Nkt Photonics A/S Microstructured optical fiber, supercontinuum light source comprising microstructured optical fiber and use of such light source
US12115235B2 (en) 2022-02-02 2024-10-15 Ultradent Products, Inc. Compositions, systems, and methods for oral delivery
KR20250004715A (ko) 2022-04-05 2025-01-08 페르톤 홀딩 에스.에이. 치아 표면들의 처리에 사용하기 위한 분말
WO2025037025A1 (en) 2023-08-16 2025-02-20 Ferton Holding S.A. Powder for slow release of active component on teeth

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4568535A (en) 1982-08-06 1986-02-04 Loesche Walter J Composition for periodontal administration
JPS59222406A (ja) 1983-06-01 1984-12-14 Teijin Ltd 歯周疾患治療用製剤及びその製造法
JPH0647532B2 (ja) 1983-08-31 1994-06-22 ジ アツプジヨン カンパニ− 歯槽骨吸収の治療
US4685883A (en) 1983-09-12 1987-08-11 Jernberg Gary R Local delivery of chemotherapeutic agents for the treatment of periodontal disease
US4892736A (en) 1983-10-07 1990-01-09 The Forsyth Dental Infirmary For Children Intra-pocket drug delivery devices for treatment of periodontal diseases
US4764377A (en) 1983-10-07 1988-08-16 The Forsyth Dental Infirmary For Children Intra-pocket drug delivery devices for treatment of periodontal diseases
IL78826A (en) 1986-05-19 1991-05-12 Yissum Res Dev Co Precursor composition for the preparation of a biodegradable implant for the sustained release of an active material and such implants prepared therefrom
WO1988003021A2 (en) 1986-10-22 1988-05-05 The Upjohn Company Treatment of gingivitis with ibuprofen or flurbiprofen
US5002769A (en) 1987-03-13 1991-03-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions for the sustained-release of chlorhexidine
US5160737A (en) 1988-05-03 1992-11-03 Perio Products Ltd. Liquid polymer composition, and method of use
US5702716A (en) 1988-10-03 1997-12-30 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
US4975271A (en) 1988-12-19 1990-12-04 Vipont Pharmaceutical, Inc. Muscosal delivery systems for treatment of periodontal disease
US5324520A (en) 1988-12-19 1994-06-28 Vipont Pharmaceutical, Inc. Intragingival delivery systems for treatment of periodontal disease
DE68918419T2 (de) 1988-12-22 1995-05-04 American Cyanamid Co Durch Phasentrennung microinkapsulierte Arzneimittelzusammensetzung zur Verminderung der Zahnkrankheit.
US5236355A (en) 1988-12-22 1993-08-17 American Cyanamid Company Apparatus for the treatment of periodontal disease
EP0374531B1 (en) 1988-12-22 1994-05-04 American Cyanamid Company Method for the treatment of periodontal disease by sustained delivery of a therapeutic agent to the periodontal pocket, composition of matter therefor and apparatus for the administration thereof
US5190981A (en) 1989-08-17 1993-03-02 Sepracor Inc. Formulation containing S(+) enantiomer of flurbiprofen or ketoprofen and method of use for oral administration for prevention and treatment of bone loss associated with periodontal disease
US5143934A (en) 1990-11-21 1992-09-01 A/S Dumex (Dumex Ltd.) Method and composition for controlled delivery of biologically active agents
US5308839A (en) 1989-12-04 1994-05-03 The Research Foundation Of State University Of New York Composition comprising non-steroidal anti-inflammatory agent tenidap and effectively non-antibacterial tetracycline
US5023769A (en) 1989-12-07 1991-06-11 Electromed International Ltd. X-ray tube high-voltage power supply with control loop and shielded voltage divider
CA2065156A1 (en) 1990-07-03 1992-01-04 Richard L. Dunn Intragingival delivery systems for treatment of periodontal disease
US5447725A (en) 1993-06-11 1995-09-05 The Procter & Gamble Company Methods for aiding periodontal tissue regeneration
WO1995004520A1 (en) 1993-08-06 1995-02-16 Embro William J Method and composition for treating muco-epidermal and epidermal pain, inflammation and infection
US5660854A (en) 1994-11-28 1997-08-26 Haynes; Duncan H Drug releasing surgical implant or dressing material
US5902110A (en) 1995-12-18 1999-05-11 The Block Drug Company Bone regeneration
US5800832A (en) 1996-10-18 1998-09-01 Virotex Corporation Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
JP4268227B2 (ja) 1997-03-18 2009-05-27 サンスター株式会社 固体粒子形成用組成物
BR9811478A (pt) 1997-07-23 2000-08-15 Perio Prod Ltd Composições de polìmero-ácido tânico para a liberação controlada de agentes farmacêuticos particularmente na cavidade oral
US6197331B1 (en) 1997-07-24 2001-03-06 Perio Products Ltd. Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavity
US5980925A (en) 1997-12-30 1999-11-09 Ethicon, Inc. High glycerin containing anti-microbial cleansers
US20010049363A1 (en) 1998-05-08 2001-12-06 Warner-Lambert Company Oral composition containing NSAIDs and essential oils
US6294192B1 (en) 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6685928B2 (en) 1999-12-07 2004-02-03 Rutgers, The State University Of New Jersey Therapeutic compositions and methods
CA2415068C (en) 2000-06-30 2009-03-10 The Procter & Gamble Company Oral compositions comprising antimicrobial agents
US20040185009A1 (en) 2003-03-19 2004-09-23 Dexcel Pharma Technologies Ltd. Composition and device for treating periodontal diseases
US8865198B2 (en) * 2010-10-25 2014-10-21 Dexcel Pharma Technologies Ltd. Method for treating a periodontal disease

Also Published As

Publication number Publication date
IL215782A0 (en) 2011-12-29
US8865198B2 (en) 2014-10-21
PT2455064T (pt) 2021-01-20
EP2455064A1 (en) 2012-05-23
US9889090B2 (en) 2018-02-13
US20150024021A1 (en) 2015-01-22
ES2842430T3 (es) 2021-07-14
EP2455064B1 (en) 2020-11-18
IL215782A (en) 2016-10-31
US20120100199A1 (en) 2012-04-26
US20160158148A1 (en) 2016-06-09
US9278064B2 (en) 2016-03-08
DE202011111037U1 (de) 2018-08-19

Similar Documents

Publication Publication Date Title
UA22227S (uk) Пристрій для обробляння води
DK3329884T3 (da) Implanterbar indretning til behandling af glaukom
BR112012033478A2 (pt) dispositivo médico
DK3520805T3 (da) Sammensætninger til behandling af myelofibrose
DK2498771T3 (da) Anvendelse af bethanechol til behandling af xerostomi
DK2550938T3 (da) Mundhygiejneanordning
LT2558105T (lt) Bardoksolono metilas, skirtas nutukimo gydymui
EP2587665A4 (en) AMPLIFIER APPARATUS
DK3124610T3 (da) Hbv-behandling
EP2671498A4 (en) ENDOSCOPE DEVICE
DK2563316T3 (da) Tandpasta til allergisk desensibilisering via mundslimhinder
IT1402667B1 (it) Apparecchio ortodontico.
DK2627345T3 (da) Formuleringer til behandling af sygdomme i de øvre luftveje
DK2613888T3 (da) Doseringsanordning
DK2489413T5 (da) Behandlingsapparat
DK2754457T3 (da) Filterindretning
EP2415408A4 (en) Treatment device
BR112012022294A2 (pt) articulador
FI20105906A0 (fi) Laite
BR112013003275A2 (pt) composição de tratamento oral
BR112012030878A2 (pt) dispositivo
DK2455064T3 (da) Indretning til behandling af periodontal sygdom
EP2659886A4 (en) Patch
DK2531124T3 (da) Indretninger til behandling af hudlæsioner
FI20105903A0 (fi) Laite